Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and Leukemia Group B (CALGB) trial 30105.

Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and Leukemia Group B (CALGB) trial 30105. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e269-74.

View in: PubMed

subject areas

Adult
Aged
Analysis of Variance
Antineoplastic Combined Chemotherapy Protocols
Area Under Curve
Carboplatin
Carcinoma, Non-Small-Cell Lung
Chemoradiotherapy
Deoxycytidine
Female
Humans
Induction Chemotherapy
Lung
Lung Neoplasms
Male
Middle Aged
Organs at Risk
Paclitaxel
Radiotherapy Dosage
Radiotherapy Planning, Computer-Assisted
Radiotherapy, Conformal

authors with profiles

Everett E. Vokes